Informational needs of patients with melanoma and their views on the utility of investigative tests

被引:10
作者
Constantinidou, A. [1 ]
Afuwape, S. A. [2 ]
Linsell, L. [2 ]
Hung, T. [1 ]
Acland, K. [2 ]
Healy, C. [1 ]
Ramirez, A. -J. [2 ]
Harries, M. [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Melanoma Grp, London SW15 6NP, England
[2] Canc Res UK, Psychosocial Grp, London, England
关键词
POSITRON-EMISSION-TOMOGRAPHY; ADVANCED CANCER-PATIENTS; BREAST-CANCER; DECISION-MAKING; PROGNOSIS; COMMUNICATION; ONCOLOGISTS; PREFERENCES; EXPERIENCE; MANAGEMENT;
D O I
10.1111/j.1742-1241.2009.02096.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Background: The aim of the study was to identify the informational needs of patients with melanoma on disease status and prognosis, and to ascertain their views on the utility of positron emission tomography (PET) and sentinel node biopsy (SNB). Patients and methods: Patients attending the weekly melanoma outpatient clinic at St Thomas' Hospital London UK between February and August 2007 participated in this cross-sectional survey. Views of 106 melanoma patients were elicited using a face-to face semi-structured questionnaire. Results: The majority of participants wanted to know everything about their disease (88%). Prognostic information (> 85%) and information on palliative care input (97%) were highly valued. More than 50% expected the doctor to impart this information without negotiation. Nearly 70% of the responders who had previously had a PET scan felt they should decide if and when the scans should be performed. Fifty three percentage had undergone the SNB because the doctor had suggested it. Conclusions: Patients with melanoma want detailed and prompt information about their disease including prognosis. Regular PET scans provide reassurance. The role of SNB is not clear to all patients.
引用
收藏
页码:1595 / 1600
页数:6
相关论文
共 27 条
[1]   Discussing prognosis: "How much do you want to know?" Talking to patients who are prepared [J].
Back, Anthony L. ;
Arnold, Robert M. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4209-4213
[2]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[3]  
*CANC RES UK, UK MAL MEL INC STAT
[4]   INFORMATION AND PARTICIPATION PREFERENCES AMONG CANCER-PATIENTS [J].
CASSILETH, BR ;
ZUPKIS, RV ;
SUTTONSMITH, K ;
MARCH, V .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (06) :832-836
[5]   Clinical use of positron emission tomography in the management of cutaneous melanoma [J].
Friedman, KP ;
Wahl, RL .
SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (04) :242-253
[6]   Informational needs of women with a recent diagnosis of breast cancer: Development and initial testing of a tool [J].
Galloway, S ;
Graydon, J ;
Harrison, D ;
EvansBoyden, B ;
PalmerWickham, S ;
BurleinHall, S ;
RichvanderBij, L ;
West, P ;
Blair, A .
JOURNAL OF ADVANCED NURSING, 1997, 25 (06) :1175-1183
[7]   Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients [J].
Gershenwald, JE ;
Thompson, W ;
Mansfield, PF ;
Lee, JE ;
Colome, MI ;
Tseng, CH ;
Lee, JJ ;
Balch, CM ;
Reintgen, DS ;
Ross, MI .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :976-983
[8]   'Hitting you over the head': Oncologists' disclosure of prognosis to advanced cancer patients [J].
Gordon, EJ ;
Daugherty, CK .
BIOETHICS, 2003, 17 (02) :142-168
[9]   Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy [J].
Grunfeld, EA ;
Maher, EJ ;
Browne, S ;
Ward, P ;
Young, T ;
Vivat, B ;
Walker, G ;
Wilson, C ;
Potts, HW ;
Westcombe, AM ;
Richards, MA ;
Ramirez, AJ .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1090-1098
[10]   The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: Impact on surgical decision making [J].
Gulec, SA ;
Faries, MB ;
Lee, CC ;
Kirgan, D ;
Glass, C ;
Morton, DL ;
Essner, R .
CLINICAL NUCLEAR MEDICINE, 2003, 28 (12) :961-965